Wenchao Xie
Yulin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Associations of obesity and novel lipid indicators in the risk of type 2 diabetes mellitus in Chinese elderly hypertensive patients.
Journal: Frontiers in endocrinology
Published: August 03, 2024
Association of metabolic score for insulin resistance with incident metabolic syndrome: a cohort study in middle-aged and older adult Chinese population.
Journal: Frontiers in public health
Published: June 22, 2024
[Retracted] Rosuvastatin suppresses platelet‑derived growth factor‑BB‑induced vascular smooth muscle cell proliferation and migration via the MAPK signaling pathway.
Journal: Experimental and therapeutic medicine
Published: January 15, 2024
CoO Nanoparticles Combined with MRI: Analysis of No-Reflow in Patients with Acute ST-Segment Elevation Myocardial Infarction after PCI and the Effect of Coronary Nicorandil.
Journal: Cellular and molecular biology (Noisy-le-Grand, France)
Published: July 09, 2022
Febuxostat Protects Human Aortic Valve Endothelial Cells From Oxidized Low-density Lipoprotein-Induced Injury and Monocyte Attachment.
Journal: Journal of cardiovascular pharmacology
Published: August 29, 2021
The efficacy and safety of edoxaban versus warfarin in preventing clinical events in atrial fibrillation: A systematic review and meta-analysis.
Journal: Anatolian journal of cardiology
Published: February 15, 2021
Latest Clinical Evidence About Effect of Acetylcysteine on Preventing Contrast-Induced Nephropathy in Patients Undergoing Angiography: A Meta-Analysis.
Journal: Angiology
Published: August 25, 2020
Transfer of exosomal microRNA-203-3p from dendritic cells to bone marrow-derived macrophages reduces development of atherosclerosis by downregulating Ctss in mice.
Journal: Aging
Published: December 17, 2019
The Efficacy And Safety Of Aspirin As The Primary Prevention Of Cardiovascular Disease: An Updated Meta-Analysis.
Journal: Therapeutics and clinical risk management
Published: December 16, 2018
Rosuvastatin may reduce the incidence of cardiovascular events in patients with acute coronary syndromes receiving percutaneous coronary intervention by suppressing miR-155/SHIP-1 signaling pathway.
Journal: Cardiovascular therapeutics
Published: October 17, 2014
Rosuvastatin suppresses platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferation and migration via the MAPK signaling pathway.
Journal: Experimental and therapeutic medicine
Published: April 24, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026